← FDA Drug Approvals (Drugs@FDA)

ANDA211084

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SIGMAPHARM LABS LLC · Approved 2022-01-12

Drug application

FDA Application #

ANDA211084

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

SIGMAPHARM LABS LLC

First approval

2022-01-12

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown